Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/the-pharmacogenetics-of-asthma-treatment-pMNn0Ku29w
References (54)
-
A. Poon, K. Tantisira, A. Litonjua, R. Lazarus, Jing-song Xu, J. Lasky-Su, J. Lima, C. Irvin, J. Hanrahan, C. Lange, S. Weiss (2008)
Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthmaPharmacogenetics and Genomics, 18
-
E. Israel, J. Drazen, S. Liggett, H. Boushey, R. Cherniack, V. Chinchilli, D. Cooper, J. Fahy, J. Fish, J. Ford, M. Kraft, S. Kunselman, S. Lazarus, R. Lemanske, R. Martin, D. McLean, S. Peters, E. Silverman, C. Sorkness, S. Szefler, S. Weiss, C. Yandava (2000)
The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.American journal of respiratory and critical care medicine, 162 1
-
A. Litonjua, J. Lasky-Su, Kady Schneiter, K. Tantisira, R. Lazarus, B. Klanderman, J. Lima, C. Irvin, S. Peters, J. Hanrahan, S. Liggett, G. Hawkins, D. Meyers, E. Bleecker, C. Lange, S. Weiss (2008)
ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts.American journal of respiratory and critical care medicine, 178 7
-
K.F. Chung, P. O’Byrne (2003)
Asthma, vol 8 -
(1997)
Highlights of the Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma -
J. Tellería, A. Blanco‐quirós, D. Varillas, A. Armentia, I. Fernández-Carvajal, M. Alonso, Ignacio Díez (2008)
ALOX5 promoter genotype and response to montelukast in moderate persistent asthma.Respiratory medicine, 102 6
-
J.J. Lima (2007)
Treatment heterogeneity in asthma: genetics of response to leukotriene modifiersMol Diagn Ther, 11
-
J. Drazen, E. Silverman, Tak Lee (2000)
Heterogeneity of therapeutic responses in asthma.British medical bulletin, 56 4
-
K. Tantisira, K. Small, A. Litonjua, S. Weiss, S. Liggett (2005)
Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways.Human molecular genetics, 14 12
-
K. Steen, M. McQueen, Alan Herbert, B. Raby, H. Lyon, D. Demeo, A. Murphy, J. Su, S. Datta, C. Rosenow, M. Christman, E. Silverman, N. Laird, S. Weiss, C. Lange (2005)
Genomic screening and replication using the same data set in family-based association testingNature Genetics, 37
-
王林, 黄亚明 (2010)
Asthma Clinical Research Network, 49
-
G. Hawkins, K. Tantisira, D. Meyers, E. Ampleford, W. Moore, B. Klanderman, S. Liggett, S. Peters, S. Weiss, E. Bleecker (2006)
Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study.American journal of respiratory and critical care medicine, 174 10
-
S. Choudhry, N. Ung, P.C. Avila (2005)
Pharmacogenetic differences in response to albuterol between Puerto Rican and Mexican asthmaticsAm J Respir Crit Care Med, 171
-
E. Bleecker, D. Postma, Rachael Lawrance, D. Meyers, H. Ambrose, M. Goldman (2007)
Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy: a pharmacogenetic analysis of two randomised studiesThe Lancet, 370
-
E. Israel, J. Drazen, S. Liggett, H. Boushey, R. Cherniack, V. Chinchilli, D. Cooper, J. Fahy, J. Fish, J. Ford, M. Kraft, S. Kunselman, S. Lazarus, Robert Jr., Richard Martin, D. McLean, S. Peters, E. Silverman, C. Sorkness, S. Szefler, S. Weiss, C. Yandava (2001)
Effect of Polymorphism of the β2-Adrenergic Receptor on Response to Regular Use of Albuterol in AsthmaInternational Archives of Allergy and Immunology, 124
-
K. Tantisira, S. Lake, E. Silverman, L. Palmer, R. Lazarus, E. Silverman, S. Liggett, E. Gelfand, L. Rosenwasser, B. Richter, E. Israel, M. Wechsler, S. Gabriel, D. Altshuler, E. Lander, J. Drazen, S. Weiss (2004)
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.Human molecular genetics, 13 13
-
K. Malmstrom, G. Rodriguez-Gomez, J. Guerra (1999)
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study GroupAnn Intern Med, 130
-
P. Enright, M. Lebowitz, D. Cockroft (1994)
Physiologic measures: pulmonary function tests. Asthma outcome.American journal of respiratory and critical care medicine, 149 2 Pt 2
-
D. Contopoulos-Ioannidis, G. Alexiou, Theodore Gouvias, J. Ioannidis (2006)
An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatmentPharmacogenetics and Genomics, 16
-
E. Silverman, D. Kwiatkowski, J. Sylvia, R. Lazarus, J. Drazen, C. Lange, N. Laird, S. Weiss (2003)
Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program.The Journal of allergy and clinical immunology, 112 5
-
K. Malmstrom, G. Rodriguez-Gomez, J. Guerra, C. Villarán, Andres Pieiro, Lynn Wei, B. Seidenberg, T. Reiss (1999)
Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic AsthmaAnnals of Internal Medicine, 130
-
E.B. Mougey, H. Feng, M. Castro (2008)
Montelukast plasma concentration associates with a common SNP in SLCO2B1Clin Pharmacol Ther, 83
-
C. Palmer, B. Lipworth, SimonMing-Yuen Lee, T. Ismail, D. Macgregor, S. Mukhopadhyay (2006)
Arginine-16 β2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterolThorax, 61
-
S. Choudhry, N. Ung, P. Avila, E. Ziv, S. Nazario, J. Casal, A. Torres, Jennifer Gorman, K. Salari, J. Rodriguez-Santana, M. Toscano, J. Sylvia, Mariaelena Alioto, R. Castro, Michael Salazar, Iván Gómez, J. Fagan, J. Salas, Suzanne Clark, C. Lilly, Henry Matallana, M. Selman, R. Chapela, D. Sheppard, S. Weiss, J. Ford, H. Boushey, J. Drazen, W. Rodriguez-Cintron, E. Silverman, E. Burchard (2005)
Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma.American journal of respiratory and critical care medicine, 171 6
-
J. Drazen, E. Israel, H. Boushey, V. Chinchilli, J. Fahy, J. Fish, S. Lazarus, R. Lemanske, R. Martin, S. Peters, C. Sorkness, S. Szefler (1996)
Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network.The New England journal of medicine, 335 12
-
W. Osler, H. Christian (1943)
OSLER??S PRINCIPLES AND PRACTICE OF MEDICINE:The American Journal of the Medical Sciences
-
Benjamin Raby, Scott Weiss (2001)
Beta2-adrenergic receptor genetics.Current opinion in molecular therapeutics, 3 6
-
Y. Shu, S. Sheardown, C. Brown, R. Owen, Shuzhong Zhang, R. Castro, Alexandra Ianculescu, L. Yue, J. Lo, E. Burchard, C. Brett, K. Giacomini (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.The Journal of clinical investigation, 117 5
-
E. Israel, V. Chinchilli, J. Ford, H. Boushey, R. Cherniack, T. Craig, A. Deykin, J. Fagan, J. Fahy, J. Fish, M. Kraft, S. Kunselman, S. Lazarus, R. Lemanske, S. Liggett, Richard Martin, N. Mitra, S. Peters, E. Silverman, C. Sorkness, S. Szefler, M. Wechsler, S. Weiss, J. Drazen (2004)
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialThe Lancet, 364
-
E. Bleecker, S. Yancey, L. Baitinger, L. Edwards, M. Klotsman, W. Anderson, P. Dorinsky (2006)
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.The Journal of allergy and clinical immunology, 118 4
-
M. Wechsler, E. Lehman, S. Lazarus, R. Lemanske, H. Boushey, A. Deykin, J. Fahy, C. Sorkness, V. Chinchilli, T. Craig, E. DiMango, M. Kraft, F. Leone, Richard Martin, S. Peters, S. Szefler, Wenlei Liu, E. Israel (2006)
β-Adrenergic Receptor Polymorphisms and Response to SalmeterolAmerican Journal of Respiratory and Critical Care Medicine, 173
-
A. Panebra, Mary Schwarb, Steven Swift, S. Weiss, E. Bleecker, G. Hawkins, S. Liggett (2008)
Variable-length poly-C tract polymorphisms of the beta2-adrenergic receptor 3'-UTR alter expression and agonist regulation.American journal of physiology. Lung cellular and molecular physiology, 294 2
-
Ellen Reihsaus, M. Innis, N. Macintyre, S. Liggett (1993)
Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects.American journal of respiratory cell and molecular biology, 8 3
-
A. Tattersfield, I. Hall (2004)
Are β2-adrenoceptor polymorphisms important in asthma—an unravelling storyThe Lancet, 364
-
S.J. Szefler, R.J. Martin, T.S. King (2002)
Significant variability in response to inhaled corticosteroids for persistent asthmaJ Allergy Clin Immunol, 109
-
R. Klein (2007)
Power analysis for genome-wide association studiesBMC Genetics, 8
-
D. Bukstein, D. Bratton, K. Firriolo, J. Estojak, S. Bird, C. Hustad, J. Edelman (2003)
Evaluation of Parental Preference for the Treatment of Asthmatic Children Aged 6 to 11 Years with Oral Montelukast or Inhaled Cromolyn: A Randomized, Open-Label, Crossover StudyJournal of Asthma, 40
-
M. Klotsman, T. York, S. Pillai, Cristina Vargas-Irwin, Sanjay Sharma, E. Oord, W. Anderson (2007)
Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukastPharmacogenetics and Genomics, 17
-
B. Kobilka, R. Dixon, T. Frielle, H. Dohlman, M. Bolanowski, I. Sigal, T. Yang-Feng, U. Francke, M. Caron, R. Lefkowitz (1987)
cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.Proceedings of the National Academy of Sciences of the United States of America, 84 1
-
S. Finotto, M. Neurath, J. Glickman, S. Qin, H. Lehr, F. Green, K. Ackerman, K. Haley, P. Galle, S. Szabo, J. Drazen, G. Sanctis, L. Glimcher (2002)
Development of Spontaneous Airway Changes Consistent with Human Asthma in Mice Lacking T-betScience, 295
-
V. Dishy, G. Sofowora, H. Xie, R. Kim, Daniel Byrne, C. Stein, A. Wood (2001)
The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.The New England journal of medicine, 345 14
-
K. Tantisira, E. Hwang, B. Raby, E. Silverman, S. Lake, B. Richter, S. Peng, J. Drazen, L. Glimcher, S. Weiss (2004)
TBX21: A functional variant predicts improvement in asthma with the use of inhaled corticosteroidsProceedings of the National Academy of Sciences of the United States of America, 101
-
P.L. Brand, E.J. Duiverman, H.J. Waalkens (1999)
Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study GroupThorax, 54
-
H. Hakonarson, U. Bjornsdottir, E. Halapi, J. Bradfield, Florian Zink, Magali Mouy, H. Helgadottir, A. Gudmundsdottir, H. Andrason, Asdis Adalsteinsdottir, K. Kristjánsson, Illugi Birkisson, T. Árnason, M. Andrésdóttir, D. Gíslason, T. Gislason, J. Gulcher, K. Stefánsson (2005)
Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients.Proceedings of the National Academy of Sciences of the United States of America, 102 41
-
M. Masoli, D. Fabian, S. Holt, R. Beasley (2004)
The global burden of asthma: executive summary of the GINA Dissemination Committee ReportAllergy, 59
-
F. Martinez, P. Graves, M. Baldini, S. Solomon, R. Erickson (1997)
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.The Journal of clinical investigation, 100 12
-
Thomas Frischer, Rolf Meinert, Radvan Urbanek, Jc Kuehr (1995)
Variability of peak expiratory flow rate in children: short and long term reproducibility.Thorax, 50
-
E. Matsui
Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services -
J. Drazen, C. Yandava, L. Dubé, Natalie Szczerback, Richard Hippensteel, A. Pillari, E. Israel, N. Schork, E. Silverman, D. Katz, J. Drajesk (1999)
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatmentNature Genetics, 22
-
P. Brand, E. Duiverman, Herman Waalkens, E. Essen-Zandvliet, K. Kerrebijn (1999)
Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long term treatment with inhaled corticosteroidsThorax, 54
-
J. Lima, Shu Zhang, A. Grant, L. Shao, K. Tantisira, H. Allayee, Jianwei Wang, J. Sylvester, J. Holbrook, R. Wise, S. Weiss, K. Barnes (2006)
Influence of leukotriene pathway polymorphisms on response to montelukast in asthma.American journal of respiratory and critical care medicine, 173 4
-
Connie Drysdale, D. McGraw, Catharine Stack, J. Stephens, R. Judson, K. Nandabalan, Kevin Arnold, G. Ruaño, S. Liggett (2000)
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.Proceedings of the National Academy of Sciences of the United States of America, 97 19
-
K. In, K. Asano, D. Beier, J. Grobholz, P. Finn, E. Silverman, E. Silverman, T. Collins, A. Fischer, T. Keith, K. Serino, S. Kim, G. Sanctis, C. Yandava, A. Pillari, P. Rubin, J. Kemp, E. Israel, W. Busse, D. Ledford, J. Murray, A. Segal, D. Tinkleman, J. Drazen (1997)
Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.The Journal of clinical investigation, 99 5
-
K. Tantisira, E. Silverman, T. Mariani, Jing-song Xu, B. Richter, B. Klanderman, A. Litonjua, R. Lazarus, L. Rosenwasser, A. Fuhlbrigge, S. Weiss (2007)
FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma.The Journal of allergy and clinical immunology, 120 6
- Publisher
- Springer Journals
- Copyright
- Copyright © 2009 by Springer Science+Business Media, LLC
- Subject
- Medicine & Public Health; Otorhinolaryngology; Pneumology/Respiratory System; Allergology
- ISSN
- 1529-7322
- eISSN
- 1534-6315
- DOI
- 10.1007/s11882-009-0002-9
- Publisher site
- See Article on Publisher Site
Abstract
The treatment response to each of the three major classes of asthma medications—β agonists, leukotriene modifiers, and inhaled corticosteroids—demonstrates substantial interindividual variability. Evidence indicates that this variability is mediated, at least in part, by genetic factors. Pharmacogenetics is the study of the role of heritable factors in the response to pharmacologic therapy. The goal of pharmacogenetics is “predictive medicine,” whereby a genetic profile, combined with clinical characteristics, can be used to predict response to medications a priori, allowing for maximal therapeutic response while minimizing side effects. In this review, we discuss the rationale behind conducting asthma pharmacogenetics studies, provide an overview of asthma pharmacogenetic phenotypes, and detail the most important results of asthma pharmacogenetics studies conducted to date. Although no specific predictive tests have been developed thus far, the existing studies serve as strong proof of concept of the applicability of pharmacogenetics in the future management of asthma.
Journal
Current Allergy and Asthma Reports – Springer Journals
Published: Dec 9, 2008